Medline Spinal Block Kits Recall Issued
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Medline Industries is recalling 4,370 kits containing Huons Bupivacaine HCL in Dextrose Injection due to quality issues with the included anesthetic.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on June 23, 2026 and geographically references United States. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, medical-devices.
What Happened
Medline Industries, LP distributed kits containing Huons Co. Bupivacaine Hydrochloride in Dextrose Injection, USP, which was subsequently recalled due to quality issues, including microbiology testing data integrity concerns and reported efficacy complaints.
Which Products Are Affected
The recall involves Medline kits labeled SPINAL BLOCK 22G QUINCKE 5S BU with Medline Kit SKU DYNJRA9026. Affected lot numbers are 26BBD235, 26ABB534, 25DBT837, 25CBH118, 24FBT403, and 24FBJ505. UDI/DI numbers are 10884389285688 (each) and 40884389285689 (case). A total of 4,370 kits are affected. Distribution was nationwide in the US, US Virgin Islands, and the countries of Bahamas, Panama, and Barbados.
What You Should Do
Consumers and healthcare facilities should verify lot numbers against the recalled products listed.
Why This Matters
This is a Class I recall involving 4,370 kits distributed worldwide, indicating a situation where use of the affected product could lead to serious adverse health consequences.
Source
FDA recall number Z-2235-2026. https://www.fda.gov
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA recall: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,098 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to June 23, 2026.
Frequently Asked Questions
Common questions about this FDA recall.